Skandinaviska Enskilda Banken (SEB)
AKYA

Skandinaviska Enskilda Banken (SEB)’s Akoya BioSciences AKYA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-72,994
Closed -$938K – 894
2022
Q2 		$938K Buy
+72,994
New +$757K 0.01% 719

Other funds holding AKYA

HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s AKYA Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Akoya BioSciences (AKYA) in Q3 2022, closing a stake of 72,994 shares — an estimated $938K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in AKYA in Q2 2022 and held it in 1 quarter. The position peaked at $938K in Q2 2022. 58 funds tracked by Wall St. Rank hold AKYA as of Q3 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Akoya BioSciences position as of Q3 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 72,994 Akoya BioSciences shares in Q3 2022, an estimated $938K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Akoya BioSciences in Q2 2022 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Akoya BioSciences position peaked at $938K in Q2 2022.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.